Brookline, MA, United States of America

Koji Kojima

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Vcell Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koji Kojima. Retrieved from https://idiyas.com/inventor/koji-kojima-wupqtuma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Koji Kojima

Introduction

Koji Kojima is a notable inventor based in Brookline, MA, who has made significant strides in the field of cellular technology. His work focuses on generating pluripotent cells de novo, which has the potential to revolutionize regenerative medicine and therapeutic applications.

Latest Patents

Kojima holds a patent for a groundbreaking technology titled "Generating pluripotent cells de novo." This patent describes methods, assays, and compositions that enable a cell to assume a more pluripotent state without the introduction of foreign genetic material. This innovation is crucial for advancing the understanding and application of stem cell biology.

Career Highlights

Kojima is affiliated with Vcell Therapeutics, Inc., where he continues to contribute to the advancement of cellular therapies. His work is characterized by a commitment to developing innovative solutions that address complex biological challenges.

Collaborations

Throughout his career, Kojima has collaborated with esteemed colleagues such as Charles Alfred Vacanti and Martin P Vacanti. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field.

Conclusion

Koji Kojima's contributions to the field of cellular technology exemplify the impact of innovative thinking in science. His patent for generating pluripotent cells de novo represents a significant advancement that could lead to transformative applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…